Investment

Research and Development Health Products Market Opportunities Bristol Myers Squibb

Google DeepMind Spinoff Plans AI-Designed Drug Trials by Year-End

Isomorphic Labs, a subsidiary of Alphabet, aims to accelerate drug development with artificial intelligence and has partnered with major pharmaceutical companies.

3 ARTICLES

6mo ago

UK Government Proposes Weight Loss Injections for Overweight Unemployed

12 ARTICLES

last yr.

Bristol Myers Squibb Acquires Karuna Therapeutics in $14 Billion Deal